Pseudo gray platelet syndrome
| Pseudo-gray platelet syndrome | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Thrombocytopenia, bleeding disorder |
| Complications | |
| Onset | |
| Duration | |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | |
| Diagnosis | Blood test, Platelet aggregation test |
| Differential diagnosis | Gray platelet syndrome, Bernard-Soulier syndrome |
| Prevention | |
| Treatment | Platelet transfusion, Desmopressin |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | N/A |
Pseudo Gray Platelet Syndrome is a rare platelet disorder characterized by mild to moderate thrombocytopenia and large, pale platelets that lack alpha granules.
Symptoms[edit]
The symptoms of Pseudo Gray Platelet Syndrome can vary greatly from person to person. Some individuals may experience no symptoms, while others may have mild to moderate thrombocytopenia, bleeding, and bruising.
Causes[edit]
Pseudo Gray Platelet Syndrome is caused by mutations in the NBEAL2 gene. This gene provides instructions for making a protein that is involved in the formation of alpha granules in platelets.
Diagnosis[edit]
Diagnosis of Pseudo Gray Platelet Syndrome is based on the clinical symptoms, a complete blood count, a review of the patient's medical history, and a thorough clinical evaluation.
Treatment[edit]
Treatment of Pseudo Gray Platelet Syndrome is focused on managing the symptoms and preventing complications. This may include platelet transfusions, iron supplementation, and other supportive treatments.